Skip to main content

Table 2 The expressions of CYP27A1, CYP7B1, IGF-1, G6PD, GFPT1, and PKM2 in tumor specimens of patients with breast carcinoma

From: Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma

 

Group A (n = 10)

Group AM (n = 10)

Group B (n = 10)

P value

CYP27A1 (n)

   

0.240

 Negative

5

8

8

 

 Positive

5

2

2

 

CYP7B1 (n)

   

0.585

 Negative

0

1

1

 

 Positive

10

9

9

 

IGF-1 (n)

   

0.315

 Negative

8

8

10

 

 Positive

2

2

0

 

G6PD (n)

   

0.010

 Negative

3

8

9

 

 Positive

7

2

1

 

GFPT1 (n)

   

0.082

 Negative

8

10

6

 

 Positive

2

0

4

 

PKM2 (n)

   

0.036

 Negative

1

6

2

 

 Positive

9

4

8

 
  1. Group A, primary breast carcinoma with recurrent metastasis during the follow-up; Group AM, corresponding recurrent metastases; Group B, primary breast carcinoma with no pathological evidence of recurrence or metastasis. P < 0.5 was considered statistically significant
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us